Home Social Media Tags

View the Latest: Social Media

Filter

List Grid

21 - 30 of 34 Results

  • A Few Thoughts After Twenty-Five Years Half In and Half Out of Journalism

    From Drew Altman

    In his latest column, KFF’s President and CEO Drew Altman dissects a few key challenges facing journalism, observed over decades overseeing KFF’s health journalism and media programs, including launching KFF Health News as its Founding Publisher in 2009.  He discusses the need for more coverage of state health policy decisions, how news can play a role in countering and not spreading misinformation, and the pros and cons of journalism awards, among others.

  • The Semi-Sad State of Consumer Protection In Health Care

    From Drew Altman

    In this column, KFF President and CEO Drew Altman explores the state of consumer protections in health care and explains why, even with consumer frustration clear, Congress is unlikely to pursue major new health insurance protections but there could be some modest steps.

  • Myths About Raw Milk and Vaccines — The Monitor

    Feature

    This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence misinformation and AI's role in spreading false mental health information.

  • How Abortion Misinformation Gives Rise to Restrictive Abortion Laws — The Monitor

    Feature

    This volume explores false claims suggesting abortions occur after birth, misleading narratives around the safety abortion pills, like mifepristone, and other tactics used to distort the safety of abortions. It also explores research on the acceptance of health misinformation and the proliferation of AI-generated fake news sites.

  • Teens, Drugs, and Overdose: Contrasting Pre-Pandemic and Current Trends

    Issue Brief

    This brief analyzes the latest CDC data on adolescent overdose deaths, finding that from 2022 to 2023, there was a small reduction in overdose fatalities among adolescents (from 721 to 708 deaths). Additionally, the synthetic opioid, fentanyl, has largely driven the increase in adolescent drug fatalities since the pandemic began, accounting for 76% of these fatalities in 2023. This analysis also explores federal and state policy responses to the drug crisis, such as requirements to stock naloxone in schools, accountability for social media companies, and national prevention education efforts.